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Abstract
Background: Hemodialysis patients have a high risk of malnutrition which is 
associated with increased mortality. Nocturnal hemodialysis (NHD) is associated 
with a significant increase in protein intake compared with conventional 
hemodialysis (CHD). It is unclear whether this leads to improved nutritional status. 
Therefore, we studied whether 1 year of NHD is associated with a change in body 
composition.
Methods: Whole body composition using Dual-Energy X-ray Absorptiometry 
(DEXA) and normalized protein catabolic rate (nPCR) were measured in 11 adult 
patients before and 1 year after the transition from CHD (12 hours dialysis/week) 
to NHD (28-48 hours dialysis/week). Similar measurements were performed in a 
matched control group of 13 patients who stayed on CHD. Differences between 
groups were analyzed with linear mixed models. 
Results: At baseline, nPCR, total mass, fat-free mass, and fat mass did not differ 
significantly between the CHD and NHD group. nPCR increased in the NHD group 
(from 0.96±0.23 to 1.12±0.20 g/kg/day; p=0.027) whereas it was stable in the CHD 
group (0.93±0.21 at baseline and 0.87±0.09 g/kg/day at 1 year, n.s.). The change 
in nPCR differed significantly between the two groups (P=0.027). We observed 
no significant differences in the course of total mass, fat-free mass, and fat mass 
during the 1-year observation period between the NHD and CHD groups. 
Conclusions: One year of NHD had no significant effect on body composition in 




Hemodialysis patients have a high prevalence of malnutrition and poor physical 
functioning with loss of muscle mass and adipose tissue1,2. Malnutrition in 
hemodialysis patients is multi-factorial, and includes reduced appetite and food 
intake3,4, protein-energy wasting as a result of chronic inflammation1,5, and reduced 
physical activity2.
Frequent nocturnal home hemodialysis (NHHD) is the dialysis treatment with 
the highest weekly clearance of uremic toxins. Nocturnal in-centre hemodialysis 
(NCHD) is an alternative for patients who have medical and/or social reasons for 
more efficient or NHD but do not have the opportunity for home hemodialysis. 
Previous studies showed that protein intake, exercise duration and capacity, 
and the quality of life improve after the transition from conventional hemodialysis 
(CHD) to frequent nocturnal hemodialysis (NHD)6-10. Theoretically, one might 
expect that the combination of an increased protein intake and increased physical 
activity during NHD would result in an increase in muscle mass and, thus, in fat-
free mass. Only a few studies examined changes in body composition after the 
transition to NHD6,11. These studies used bioelectrical impedance analysis6 or skin 
fold thickness11 and did not observe significant changes in body composition. 
Dual Energy X-ray Absorptiometry (DEXA), which is considered as the reference 
method because of its high accuracy12,13, has not been used to study changes in 
body composition after the transition to NHD. 
The goal of this study was to determine whether 1 year of treatment with 
NHD is associated with a change in body composition compared with 1 year of 
continued CHD. 
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Methods
All patients aged ≥18 years on maintenance hemodialysis who were scheduled 
to start on NHD between august 2008 and august 2011 were eligible for this 
prospective observational study. Exclusion criteria were life expectancy <1 year, 
metal implants that interfere with DEXA measurement, and absence of informed 
consent. For each patient who started on NHD a control patient on CHD (matched 
for age, gender, and dialysis vintage) was identified and requested to participate at 
3 months after the transition of the index patient to NHD. 
DEXA whole-body composition scans were performed at baseline and after 
one year with a Hologic Discovery A (Hologic Inc., Bedford, MA, USA). Enhanced 
Analysis Hologic System Software Version 3.3 was used to calculate lean mass 
(LM), fat-free mass (FFM), fat mass (FM), total mass (TM), and bone-mineral content 
(BMC). FFM was computed by adding LM and BMC. To standardize the hydration 
status, DEXA scans were performed 2-3 hours post-dialysis in both groups. 
Patients in the NHD group received 8 hours of single-needle dialysis with 
blood and dialysate flows of 150 and 300 ml/min, respectively. NCHD patients were 
dialyzed every other night and NHHD patients dialyzed 5-6 nights per week. CHD 
patients in the control group were on a thrice weekly 4 hours dialysis schedule 
using double-needle dialysis and blood and dialysate flows of 250-350 and 500 ml/
min, respectively. All patients were dialyzed with low-flux polysulphone dialyzers 
and low-molecular-weight heparin as anticoagulant. 
Dry weight was evaluated clinically (peripheral edema, signs of pulmonary 
congestion, intra- and interdialytic blood pressure course, muscle cramps) in 
combination with yearly pre-dialysis cardiothoracic ratio on chest X-ray as a 
surrogate marker of hydration status. For this study, the cardiothoracic ratios at 
baseline and after 1 year were blindly assessed by one of the authors (C.F.M.F.). All 
patients had regular contact with the dietician every 4-6 weeks in accordance with 
usual clinical practice. 
Patients’ characteristics were assessed at the time of the first DEXA scan. Body 
mass index (BMI) was calculated as: post-dialysis weight (kg)/length (m)2. Pre-
dialysis plasma levels of urea, hemoglobin, and albumin, as well as equilibrated 
Kt/V and normalized (for dry body weight) protein catabolic rate (nPCR) were 
measured at baseline and after 1 year14,15. Residual renal function was defined as 
diuresis >200 ml/24 h.
The null-hypothesis of our study was that there is no difference in the course 
of FFM during 1 year between patients on CHD and those on NHD.




Data are reported as mean±SD for continuous variables with normal distributions, 
median (interquartile range [IQR]) for skewed variables, and number (percent) for 
categorical data. Comparisons between groups were made with the Mann-Whitney 
U test. Comparisons between baseline and 1-year were made with paired t-test. 
The primary outcomes were changes in LM, FFM, FM, and TM. Secondary 
outcomes were changes in nPCR and albumin. 
Linear mixed models were applied to analyze differences in the course of the 
primary and secondary outcome measurements between the groups16. For each 
of the response (dependent) variables, fixed effects were estimated for the groups 
NHD and CHD, and for time and random effects for patients. Since gender17, age18, 
and dialysis vintage1,19 are known to affect nutritional status and body composition, 
we included these as covariates16. This enabled us to estimate the fixed group and 
time effects controlling for gender, age and dialysis vintage as well as for individual 
patient levels.
All statistical analyses were performed with SPSS version 20 (SPSS inc., IBM 
company, USA) and statistical programming language R (R Development Core 
Team, 2011). Two-tailed P-values <0.05 were considered statistically significant.
Results
Patients characteristics
During the study period, a total of 21 patients made the transition from CHD 
to NHD. Seven of these patients went back to CHD within 3 months after the 
transition because of difficulty with sleeping (n=1), sepsis (n=1), heart failure 
with hypotension (n=4), and renal transplantation (n=1). The remaining 14 NHD 
patients were matched with 14 CHD patients. Three of these 14 NHD patients did 
not complete one year of follow-up on NHD and went back to CHD because of 
miscellaneous reasons: heart failure with hypotension, difficulty with sleeping, and 
newly discovered malignancy. In the CHD group, only 1 patient did not complete 
the 1-year follow-up because of renal transplantation. The patients who dropped 
out of the NHD group were more frequently of male gender (P=0.072) and were 
significantly older (P=0.001), compared with patients that completed 1 year of 
NHD (Supplementary Table 1).
The final study group consisted of 11 patients who completed 1 year of 
NHD. Of these patients, 6 were on NHHD and 5 were on NCHD. The control group 
consisted of 13 patients on CHD (Table 1). 
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Gender, female (n) 5 (45%) 5 (38%)
Race (n)
    Caucasian
    Asian







Age (years), median (IQR) 41 (36-51) 49 (36.5-66.5)
Dialysis vintage (years), median (IQR) 3 (1-6) 3 (1-5)
BMI (kg/m2), mean±SD 24.7±3.7 25.5±3.9
Diabetes Mellitus (n) 1 (9%) 2 (15%)
CRP (mg/l), median (IQR) 5.5 (5-11.25) 5.0 (5-8)
Residual diuresis (n) 4 (36%) 4 (31%)
Primary renal disease (n)
    ADPKD 1 (9%) 2 (15%)
    FSGS 3 (23%)
    Glomerulonephritis 1 (9%)
    IgA Nephropathy 3 (27%) 1 (8%)
    HUS 1 (9%)
    Urologic cause 2 (18%) 2 (15%)
    Diabetic Nephropathy 1 (9%) 2 (15%)
    Etiology unknown 2 (18%) 3 (23%)
IQR: Interquartile Range; BMI: Body Mass Index; CRP: C-reactive Protein; 
ADPKD: Autosomal Dominant Polycystic Kidney Disease; FSGS: Focal 
Segmental Glomerulosclerosis; HUS: Hemolytic-Uremic Syndrome
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Body composition
Gender, dialysis vintage, and to a lesser extent, age influenced body composition 
(Table 2). This indicates that it was appropriate to include these as covariates in the 
linear mixed models.
Table 2. Effects of the covariates in the total study population (n=24).











BMI (kg/m2) 3.14 0.060 0.04 0.444 -0.60 0.012
CTR 0.01 0.515 0.00 0.781 -0.00 0.747
Lean mass (kg) -11.64 0.000 0.09 0.096 -0.16 0.494
Fat-free mass (kg) -11.99 0.000 0.10 0.081 -0.18 0.469
Fat mass (kg) 14.27 0.001 0.08 0.488 -1.48 0.010
Total mass (kg) 2.28 0.635 0.18 0.220 -1.65 0.018
Fat (%) 16.8 0.000 0.03 0.719 -1.17 0.012
Hemoglobin (mmol/) 0.01 0.955 0.00 0.981 -0.01 0.703
Albumin (g/l) 0.98 0.276 -0.08 0.007 -0.15 0.224
Kt/V 0.69 0.011 -0.01 0.430 -0.03 0.394
nPCR (g/kg/day) -0.04 0.561 0.00 0.456 -0.01 0.282
P value indicates significance of the effect of covariate (gender, age, dialysis 
vintage) on the measurements in the total study population (n=24). BMI: body 
mass index; CTR: cardiothoracic ratio; nPCR: normalized protein catabolic 
rate.
As shown in Table 3, we found no significant differences in the course of body 
mass index and cardiothoracic ratio between the NHD and CHD group. There were 
no significant changes in the course of LM, FFM, FM, TM, and the percentage fat 
between the NHD and CHD group (Table 3, Figure 1). 
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Table 3. Changes in body composition and laboratory measurements.
Mean ±SD
Interaction effects 
between NHD and 




Pa Effect size Pb
Body mass index
(kg/m2)
NHD 24.7±3.7 24.8±3.8 0.753
0.16 0.685
CHD 25.8±3.9 25.8±3.8 0.782
Cardiothoracic 
ratio 
NHD 0.45±0.03 0.45±0.06 0.605
-0.03 0.066
CHD 0.46±0.03 0.48±0.04 0.026
Lean mass (kg) NHD 49.9±8.0 48.6±8.2 0.104
-0.38 0.743
CHD 51.1±7.8 50.2±7.3 0.246
Fat-free mass (kg) NHD 52.3±8.3 50.9±8.5 0.095
-0.38 0.741
CHD 53.5±8.1 52.4±7.6 0.222
Fat mass (kg) NHD 25.3±11.5 26.9±10.5 0.163
1.22 0.368
CHD 24.8±10.4 25.2±9.3 0.606
Total mass (kg) NHD 77.6±12.9 77.8±12.2 0.855
0.83 0.490
CHD 78.2±10.6 77.6±10.8 0.168
Fat (%) NHD 31.8±10.7 34.0±10.0 0.051
1.29 0.362
CHD 31.1±10.5 32.0±8.9 0.352
Hemoglobin 
(mmol/l)
NHD 7.1±0.74 7.5±0.55 0.300
0.45 0.200
CHD 7.3±0.62 7.2±0.35 0.635
Albumin (g/l) NHD 41.4±2.69 42.6±2.07 0.151
1.10 0.236
CHD 39.3±2.59 39.4±2.53 0.877
Kt/V NHD 4.38±0.41 8.11±1.34 0.000
3.87 0.000
CHD 4.42±0.60 4.28±0.53 0.460
nPCR (g/kg/day) NHD 0.96±0.23 1.12±0.20 0.029
0.23 0.027
CHD 0.93±0.21 0.87±0.09 0.358
 
aP value indicates significance of the difference within groups between 
baseline and after 1 year (paired t-tests). bP value indicates significance of 
the difference in the course of variables over 1 year between the two groups 
(linear mixed models). NHD: nocturnal hemodialysis; CHD: conventional 
hemodialysis; nPCR: normalized protein catabolic rate.
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Lines and error bars indicate mean±SD. The solid line indicates nocturnal 
hemodialysis and the dashed line indicates conventional hemodialysis. 
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Laboratory measurements
At baseline, Kt/V and nPCR did not differ significantly between groups. Both Kt/V 
and nPCR increased significantly in the NHD group, whereas both were stable in 
the CHD group. Courses of Kt/V (P<0.001) and nPCR (P=0.027) differed significantly 
between the two groups (Table 3, Figure 2). The baseline levels and courses of 
albumin (Figure 3) and hemoglobin levels did not differ significantly between NHD 
and CHD patients (Table 3). 
Figure 2. Changes in nPCR 
















Lines and error bars indicate mean±SD. The solid line indicates nocturnal 
hemodialysis and the dashed line indicates conventional hemodialysis.
Figure 3. Changes in albumin 













Lines and error bars indicate mean±SD. The solid line indicates nocturnal 





In this study we found no significant changes in body composition during 1 year of 
NHD despite a significantly higher protein intake in these patients. Therefore, we 
could not reject the null-hypothesis that there is no difference in the course of the 
FFM during 1 year between patients on CHD and those on NHD.
Our results are in line with that of other studies. Recently, Kaysen et al.6 
observed no significant differences in the course of body composition, measured 
with a single-frequency bioelectrical impedance analysis between patients on 
daily hemodialysis and NHD. Spanner et al.11 studied patients on short daily (n=11) 
and NHD (n=12), and observed a significant increase in arm muscle area in the 
short daily hemodialysis group but no significant change in the NHD group during 
18 months of follow-up and LM and FM, measured using skin fold thickness, did 
not change in either group. Notably, single frequency bioimpedance does not 
distinguish between intra- and extracellular fluid, and the measurement of muscle 
area and skin fold thickness is relatively insensitive13.
In this study, protein intake increased significantly in the NHD group whereas 
protein intake did not change in the CHD group. This finding is in accordance with 
the larger study by Kaysen et al.6. Protein intake also increased significantly after 
the conversion from conventional to NHD in two smaller studies7,8. 
The remarkable finding of this study is that protein intake increased 
significantly in the NHD group whereas body composition did not change. The 
same discrepancy was found in the study by Kaysen et al.6. How to explain this 
paradox? Ikizler20 suggested that hemodialysis induces a net protein catabolic 
state at the whole-body level and in skeletal muscle. Various studies indeed 
showed that hemodialysis while fasting is associated with a negative protein 
balance20-22. During NHD, patients are asleep and generally do not eat. It could be 
possible that the significant increase in protein intake in NHD patients is offset by 
increased amino acid loss as a result of more intensive dialysis and/or by increased 
hemodialysis-associated catabolism. Notably, Veeneman et al.23 previously showed 
that consumption of a protein- and energy-enriched meal during hemodialysis 
resulted in a positive protein balance. It is questionable whether a similar 
intervention during nocturnal hemodialysis would result in an increase in FFM. 
Another explanation for the lack of an increase in FFM despite a significantly higher 
protein intake is a lack in physical activity. In a recent study, it was found that NHD 
had no significant effects on physical performance, health, and functioning in the 
NHD compared with the CHD group24. It is conceivable that an increase in physical 
activity is necessary for the higher protein intake to translate into an increase in fat-
free (muscle) mass in NHD patients.
A limitation of our study is the small number of participants in the NHD 
group because of a relatively high drop-out rate. However, the increase in protein 
intake in the NHD patients corresponds well with that found in other studies. NHD 
patients who did not complete the study were significantly older compared with 
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patients who completed the study. Thus, despite the fact that the NHD group was 
enriched for younger (and probably physically more active patients), we still did 
not observe a favorable effect of NHD on body composition parameters like FFM. 
The patients were not randomized between CHD and NHD. However, the inclusion 
of a control group that was matched for important confounders like age, gender, 
and dialysis vintage, reduced bias. The matching for age was not optimal, due to 
the drop out of predominantly older patients in the NHD group. Other limitations 
include that hydration status was assessed clinically and not with a more objective 
measure such as bioimpedance and the absence of tests of physical performance. 
Strengths of this study are the use of DEXA as an accurate and save method 
for the measurement of the change in body composition12,13 and standardization 
of the timing of the DEXA shortly after the dialysis sessions when the patient is on 
dry weight. 
In conclusion, in this relatively small study, 1 year of nocturnal hemodialysis 
had no significant effect on body composition in comparison with CHD patients, 
despite a significantly higher protein intake in NHD patients. 
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Supplementary Table 1: Comparison between NHD patients who completed 1 
year of NHD and those who made a modality switch back to CHD during the 
study period.




who dropped out 
during the study 
(n=10)
P
Gender, female (n) 5 (45%) 1 (10%) 0.072
Race (n)
    Caucasian
    Asian







Age (years), median (IQR) 41 (36-51) 59 (50-71,5) 0.001
Dialysis vintage (years), 
median (IQR)
3 (1-6) 3.5 (2-5) 0.462
BMI, mean±SD 24.7±3.7 28.2±5.6 0.098
Diabetes Mellitus (n) 1 (9%) 2 (20%) 0.476





Residual diuresis (n) 4 (36%) 1 (10%) 0.157 
Primary renal disease (n)
    ADPKD 1 (9%) 1 (10%)
    FSGS 2 (20%)
    Glomerulonephritis 1 (9%) 3 (30%)
    IgA Nephropathy 3 (27%) 2 (20%)
    HUS 1 (9%)
    Urologic cause 2 (18%)
    Diabetic Nephropathy 1 (9%) 1 (10%)
    Etiology unknown 2 (18%) 1 (10%)
IQR: Interquartile Range; BMI: Body Mass Index; CRP: C-Reactive Protein; 
ADPKD: Autosomal Dominant Polycystic Kidney Disease; FSGS: Focal 
Segmental Glomerulosclerosis; HUS: Hemolytic-Uremic Syndrome.

